Infopack for relapsed and/or refractory myeloma patients

This Infopack is for myeloma patients whose myeloma has returned following or during treatment. It explains reasons why myeloma may relapse, how the relapse will be recognised and the treatments available. It also explains why myeloma can become refractory to treatments, and what options may be available for these patients.

Last updated: June 2019
Review date: June 2022